IL6 and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, compared to the rHDL-0 and rHDL-2 groups, the rHDL-1 injected group demonstrated a five-fold (p < 0.001) and 4.6-fold (p < 0.001) reduction in the IL-6-stained area, respectively, highlighting the efficacy of Raydel policosanol in inhibiting CML-induced Il-6 production.